OBJECTIVES: To determine whether the incidence and duration of bleeding complications
after transrectal prostate biopsy (PB) in patients not discontinuing low-dose aspirin (LDA) …

OBJECTIVE To determine whether low‐dose aspirin increases morbidity after transrectal
ultrasonography‐guided sextant prostate biopsy. PATIENTS AND METHODS In a single …

PURPOSE: To determine whether the peri-procedural administration of low-dose aspirin
increases the risk of bleeding complications for patients undergoing extended prostate …

AIM: To assess whether patients taking aspirin were more likely to experience bleeding
complications after transrectal ultrasound (TRUS)-guided prostate biopsy. MATERIALS AND …

INTRODUCTION: The management of anti-platelet therapy in the peri-operative period is a
source of great concern. The dilemma is between whether to stop these agents peri …

Aim To determine whether patients undergoing transrectal ultrasound (TRUS)-guided
prostate biopsy with increased sampling numbers are more likely to experience bleeding …

OBJECTIVE To compare, in a prospective study, bleeding (in three categories, ie
haematuria, haematospermia and rectal) and consultations with the general practitioner …

Objective: To determine the relation between ASA ingestion and the incidence of bleeding
complications after transrectal ultrasound (TRUS)-guided biopsy of the prostate. Methods …

Purpose Historically, it was thought that hemorrhagic complications were increased with
transrectal ultrasound-guided prostate biopsies (TRUS biopsy) of patients receiving …

AIM: To determine the relation between warfarin use and the frequency of bleeding
complications after biopsy of the prostate guided by transrectal ultrasound (TRUS) …